Baker Bros. Advisors LP 13D and 13G filings for Neoleukin Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-10-10 4:42 pm Purchase |
2023-10-05 | 13D | Neoleukin Therapeutics, Inc. NLTX |
Baker Bros. Advisors LP | 473,667 19.990% |
473,667 (New Position) |
Filing |